News
- Author:
- Randy Dotinga
Publish date: May 23, 2023
Researchers blame racism for both findings of an analysis of three North Carolina hospitals.
News
- Author:
- Randy Dotinga
Publish date: May 22, 2023
Most patients in a small study reached undetectable measurable disease after taking combo therapy for high-risk CLL.
News
- Author:
- Randy Dotinga
Publish date: May 18, 2023
Oncologists are still trying to understand the best drug targets and the value of combo treatments.
News
- Author:
- Randy Dotinga
Publish date: May 17, 2023
In a small study, 56% of oncologists revised plans after getting results of HER2DX tests.
News
- Author:
- Randy Dotinga
Publish date: May 12, 2023
But T-DXd demonstrates a manageable safety profile consistent with prior reports, says the author of a new paper.
News
- Author:
- Randy Dotinga
Publish date: May 12, 2023
“Many of these trials have been included in clinical guidelines and cited extensively in systematic reviews and meta-analyses, especially those rel...
News
- Author:
- Randy Dotinga
Publish date: May 8, 2023
Researchers suspect that multiple factors – including biology – could be behind the racial disparity found in this large study.
News
- Author:
- Randy Dotinga
Publish date: April 24, 2023
On average, physicians in 18 specialties netted $1.9 million a year, according to a new AMN Healthcare report.
News
- Author:
- Randy Dotinga
Publish date: April 20, 2023
A young Lebanese-American physician scientist keeps ‘smoldering’ myeloma in his sights and a sick relative in mind.
News
- Author:
- Randy Dotinga
Publish date: April 10, 2023
Best outcomes came when immunotherapy followed radiotherapy by 1-12 months.
News
- Author:
- Randy Dotinga
Publish date: April 10, 2023
A new report offers more insight into the connection between cumulative smoking levels and lung cancer.
News
- Author:
- Randy Dotinga
Publish date: April 10, 2023
Patient outcomes didn’t hinge on whether oncologists treated the brain or lung first.
News
- Author:
- Randy Dotinga
Publish date: March 30, 2023
Public-private consortium plans to develop new approaches to clinical studies.
News
- Author:
- Randy Dotinga
Publish date: March 28, 2023
Doctors treating CLL and other B-cell cancers are blindsided by a lack of research into acquired hypogammaglobulinemia prophylactics.
News
- Author:
- Randy Dotinga
Publish date: March 20, 2023
As patients fare better with targeted therapy, physicians say they can tolerate more procedures.
